Search Results

1 - 10 of 95 items :

  • "peripheral arterial disease" x
Clear All

REFERENCES 1. O’Hare AM, Glidden DV, Fox CS, Hsu CY. High prevalence of peripheral arterial disease in persons with renal insufficiency: results from the National Health and Nutrition Examination Survey 1999-2000. Circulation 2004; 109:320. 2. O’Hare AM, Vittinghoff E, Hsia J, Shlipak MG. Renal insufficiency and the risk of lower extremity peripheral arterial disease: results from the Heart and Estrogen/Progestin Replacement Study (HERS). J Am Soc Nephrol 2004; 15:1046. 3. Wattanakit K, Folsom AR, Selvin E, et al. Kidney function and risk of peripheral arterial

. Bratislavske Lekarske Listy. 2007; 108(7): 297–300. 6. Undas A, Nowakowski T, Cieśla-Dul M, Sadowski J. Abnormal plasma fibrin clot characteristics are associated with worse clinical outcome in patients with peripheral arterial disease and thromboangiitis obliterans. Atherosclerosis. 2011; 215(2): 481–6. 7. Casini A, Neerman-Arbez M, Ariëns RA, Moerloose PD. Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management. Journal of Thrombosis and Haemostasis. 2015; 13(6): 909–19. 8. Bosevski M, Kostoska S, Tosev S, Borozanov V. Prognostic importance of

References 1. Alzamora MT, Forés R, Pera G et al. Incidence of peripheral arterial disease in the ARTPER population cohort after 5 years of follow-up. BMC Cardiovasc Disord. 2016;16(1):8 DOI:10.1186/s12872-015-0170-6 2. George J, Rapsomaniki E, Pujades-Rodriguez M et al. How Does Cardiovascular Disease First Present in Women and Men? Incidence of 12 Cardiovascular Diseases in a Contemporary Cohort of 1 937 360 People. Circulation. 2015;132:1320-1328. 3. Criqui MH, Aboyans V. Epidemiology of Peripheral Artery Disease. Circ Res. 2015;116:1509-1526. 4. Hak AE

with acute myocardial infarction. Clin Lab 2014; 60(8): 1351-6. 7. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, et al. Peripheral arterial disease detection, awareness and treatment in primary care. JAMA 2001; 286: 1317-24. 8. Steg PG, Bhatt DL, Wilson PW, D’Agostino R Sr, Ohman EM, Rother J, et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007; 297: 1197-206. 9. Ye Z, Smith C, Kullo IJ. Usefullness of red cell distribution width to predict mortality in patients with peripheral artery disease. Am

References 1. Willerson J T, Cohn JN, Wellens HJJ, Holmes DR Jr, eds. Cardiovascular Medicine 2. London: Springer 2007; 1681–703. 2. Marso S P, Hiatt WR. Peripheral arterial disease in patients with diabetes. J Am Coll Cardiol 2006; 47(5): 921–9. 3. Leng GC, Lee AJ, Fowkes FG, et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in general population. Int J Epidemiol 1996; 25: 1172–81. 4. Diehm C, Allenberg JR, Pittrow D, et al; German Epidemiological Trial on Ankle Brachial Index Study Group

References 1. Murabito JM, D’Agostino RB, Silbershatz H, Wilson PWF. Intermittent Claudication - A Risk Profile From The Framingham Heart Study. Circulation, 1997;96:44-49. 2. Khan S, Flather M, Mister R et al. Characteristics and Treatments of Patients with Peripheral Arterial Disease Referred to UK Vascular Clinics: Results of a Prospective Registry. European Journal of Vascular and Endovascular Surgery, 2007;33:4:442–450. 3. Bainton D, Sweetnam P, Baker I, Elwood P. Peripheral vascular disease: consequence for survival and association with risk factors in the

ABBREVIATIONS CA - Conventional Angiography CE-MRA - Contrast enhancement Magnetic Resonance Angiography CTA - Computed Tomography angiography CMA - Cost-minimization analysis DUS - Duplex Ultrasound Scanning PAD - Peripheral Artery Disease REFERENCES 1. Petersen S, Peto V, Rayner M, Leal J, Luengo-Fernandez R & Gray A. (2005). European Cardiovascular Disease Statistics: London: British Heart Foundation. 2. Selvin E & Erlinger TP. (2004). Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National

REFERENCES 1. Barbarash OL, Zykov MV, Pecherina TB, et al. The Prognostic Value of Peripheral Artery Diseases in Patients with ST-Segment Elevation Myocardial Infarction. Dis Markers . 2013;35(6):877-882. 2. Yakubov S. Polyvascular atherosclerotic disease: recognizing the risks and managing the syndrome. Curr Med Res Opin . 2009;25(11):2631-2641. 3. Alahdab F, Wang AT, Elraiyah TA, et al. A systematic review for the screening for peripheral arterial disease in asymptomatic patients. J Vasc Surg . 2015;61(3S):42S-53S. 4. Folsom AR, Kronmal RA, Detrano RC, et al

REFERENCES 1. Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circulation Research . 2015;116:1509-1526. 2. Davies GM. Criticial Limb Ischemia: Epidemiology. Methodist Debakey Cardiovasc J . 2012;8(4):10-14. 3. Sarangi S, Srikant B, Rao DV, Joshi L, Usha G. Correlation between peripheral arterial disease and coronary artery disease using ankle brachial index-a study in Indian population. Indian Heart J . 2012;64(1):2-6. 4. Hussein AA, Uno K, Wolski K, et al. Peripheral Arterial Disease and Progression of Coronary Atherosclerosis. J Am Coll

factors levels and their insufficient therapeutic control. The aim of the present study was to compare demographic, clinical and biochemical characteristics, including inflammatory markers, according to the nutritional status of patients with verified atherosclerotic disease (carotid and peripheral). Materials and Methods This cross-sectional study involved 1045 consecutive patients who were referred to the Vascular Surgery Clinic Dedinje in Belgrade, Serbia, because of carotid disease or peripheral arterial disease (PAD). The study was conducted during the period April